Oxycodone Mundipharma 5 mg

Oxycodone Mundipharma 5 mg is a medicine authorised by Swissmedic under authorisation number 69424. The authorisation holder is Mundipharma Regulatory GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 11 August 2023 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.

  • Dispensing category A+
  • Authorisation number 69424
  • Synthetic medicines
Authorisation data
Authorisation number69424
NameOxycodone Mundipharma 5 mg
Full nameOxycodone Mundipharma 5 mg, Kapseln
Authorisation holderMundipharma Regulatory GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryA+ · Prescription with conditions
ATC codenot stated
First authorisation11 August 2023
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Oxycodone Mundipharma 5 mg, KapselnA+11 August 2023
2Oxycodone Mundipharma 10 mg, KapselnA+11 August 2023
3Oxycodone Mundipharma 20 mg, KapselnA+11 August 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
The Swissmedic export lists no pack sizes for this medicine.

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Oxycodone Mundipharma 5 mg authorised in Switzerland?

Yes. Oxycodone Mundipharma 5 mg is authorised by Swissmedic under authorisation number 69424, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Oxycodone Mundipharma 5 mg have?

Oxycodone Mundipharma 5 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.

Who is the authorisation holder of Oxycodone Mundipharma 5 mg?

The authorisation holder is Mundipharma Regulatory GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com